Loading...
Targeting the neurovascular unit for treatment of neurological disorders
Drug discovery for CNS disorders has been restricted by the inability for therapeutic agents to cross the blood-brain barrier (BBB). Moreover, current drugs aim to correct neuron cell signaling, thereby neglecting pathophysiological changes affecting other cell types of the neurovascular unit (NVU)....
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2010
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3092634/ https://ncbi.nlm.nih.gov/pubmed/21172386 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pharmthera.2010.12.004 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|